Utah Study Evaluating Apneic Oxygenation for Emergency Department Intubation

NCT ID: NCT02961933

Last Updated: 2020-02-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

500 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-12-31

Study Completion Date

2020-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will determine rates of first pass success without hypoxemia in emergency department intubations with and without the use of apneic oxygenation by nasal cannula.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Apneic oxygenation

Group Type EXPERIMENTAL

Apneic oxygenation

Intervention Type OTHER

Nasal cannula apneic oxygenation

non-apneic oxygenation

Group Type ACTIVE_COMPARATOR

Pre-oxgenation with NRB, NIPPV, BVM

Intervention Type OTHER

Pre-oxygenation with non-rebreather mask, non-invasive positive pressure ventilation, or bag-valve mask

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Apneic oxygenation

Nasal cannula apneic oxygenation

Intervention Type OTHER

Pre-oxgenation with NRB, NIPPV, BVM

Pre-oxygenation with non-rebreather mask, non-invasive positive pressure ventilation, or bag-valve mask

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

\- Patients requiring emergent Rapid Sequence or Delayed Sequence endotracheal intubation with administration of a neuromuscular blocker (Succinylcholine, Rocuronium)

Exclusion Criteria

* Known prisoners
* Patients in cardiac arrest
* Patients who are intubated without the use of neuromuscular blockade (i.e., cardiac arrest, awake intubation).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Utah

OTHER

Sponsor Role collaborator

Intermountain Health Care, Inc.

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Bryant, MD

Role: PRINCIPAL_INVESTIGATOR

Intermountain Health Care, Inc.

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Intermountain Medical Center

Murray, Utah, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Valerie Aston, MBA, RT

Role: CONTACT

801-507-4606

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Valerie Aston, MBA, RT

Role: primary

801-507-4606

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

1050200

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Four Methods of Pre-oxygenation
NCT02708862 COMPLETED NA
Ventilation Monitoring in OHCA
NCT04988906 COMPLETED NA
Pulse Oximeter Motion Study
NCT03156140 COMPLETED NA